期刊文献+

冠心病患者抗凝、纤溶功能及单核细胞上CD 40-CD 40L系统表达的研究 被引量:3

Study on Anticoagulant-Fibrinolytic Function and Expression of CD 40-CD 40 Ligand System on Monocytes in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的观察冠心病(CHD)患者抗凝、纤溶功能及单核细胞上CD40-CD40L系统表达情况以及两者间的相关性。方法将36例CHD病例分为2组:心绞痛(SA)组和冠脉综合征(ACS)组,分别检测血浆中PC活性、D-dimer(D-D)、tPA、PAI-1含量、游离型配体sCD40L浓度和外周血单核细胞上CD40、CD40L表达水平,并与19例正常对照组相比较。结果ACS组、SA组患者血浆PC活性明显低于健康对照组;ACS组、SA组患者血浆D-D含量明显高于健康对照组;ACS组、SA组患者血浆tPA含量明显高于健康对照组;ACS组患者血浆PAI-1含量明显高于SA组、健康对照组;ACS组患者外周血单核细胞上CD40的表达水平明显高于SA组、健康对照组;ACS组、SA组患者血浆sCD40L浓度明显高于健康对照组(P<0.05);外周血单核细胞CD40与CD40L表达水平与血浆sCD40L浓度三者间进行Pearson相关系数分析,结果显示外周血单核细胞CD40与CD40L表达水平呈正相关(r=0.41,P=0.002);外周血单核细胞CD40表达水平与血浆sCD40L浓度呈正相关(r=0.367,P=0.006);血浆PAI-1含量与外周血单核细胞CD40表达水平、血浆sCD40L浓度呈正相关(r=0.328,P=0.014;r=0.401,P=0.002)。结论CHD患者抗凝、纤溶功能对评估CHD的预后、指导治疗有一定的价值。CD40-CD40L通路可能与ACS的形成有关,阻断CD40-CD40L信号途径可能成为防治AS的一个重要靶点。 Objective To investigate anticoagulant-fibrinolytic function and expression of CD 40-CD 40 ligand system on monocytes and the correlation between two system in patients with coronary heart disease. Methods 36 CHD patients was divided two groups:stable angina(SA), acute coronary syndrome (ACS). (CHD) In these patients, activity of plasma PC, contents of plasma D- dimer( D- D), tPA and PAI- 1 ,concentrates of plasma soluble CD 40 ligand (sCD 40L) , the expression level of CD 40 and CD 40L on peripheral blood mononnclear cells( PBMC), was detected, and was compared with 19 health adult. Results The activity of plasma PC in patients with CHD was significantly lower than healthy controls. The contents of plasma D- D in patients with CHD was significantly higher than healthy controls. The contents of plasma tPA in patients with CHD was significantly higher than healthy controls. The contents of plasma .PAI-1 in patients with ACS was significantly higher than patients with SA and healthy controls. The expression of CD 40 on PBMC in patients with ACS was significantly higher than patients with SA and healthy controls. The concentrates of plasma sCD 40L in patients with CHD was significantly higher than healthy controls ( P 〈 0.05 ). There was positive correlation of the expression of between CD 40 and CD 40L on monoeytes in peripheral blood(r =0. 41 ,P =0. 002);there was positive correlation between the expression of CD 40 on monocytes in peripheral blood and concentrations of sCD 40L in plasma( r = 0. 367, P = 0. 006) ;there was positive correlation between the contents of plasma PAI- 1 and the expression of CD 40 on monocytes in peripheral blood,concentrations of sCD 40L in plasma(r =0. 328 ,P =0. 014; r =0. 401 ,P =0. 002). Conclusion Study of the anticoagulant- fibrinolytie function in CHD patients had a certain value to assess prognosis and guide treatment of CHD. CD 40 - CD 40L pathway may correlate with the formation of ACS, blockade of CD 40- CD 40L system may be an important target for prevention and cure of AS.
出处 《血栓与止血学》 2008年第6期250-253,共4页 Chinese Journal of Thrombosis and Hemostasis
关键词 冠心病 蛋白C D-二聚体 纤溶酶原 CD 40 Coronary heart disease Protein C D- dimer Plasminogen CD 40
  • 相关文献

参考文献3

二级参考文献22

  • 13GPP Proposal TS 25. 212 - 2000, Technical specification group radio access network; multiplexing and channel coding (FDD)[S].
  • 2Ross R. N Engl J Med, 1999, 340: 115-126
  • 3Schonbeck U et al. Cell Mol Life Sci, 2001, 58: 4-43
  • 4Frostegard J et al. Atherosclerosis, 1999, 145: 33-43
  • 5Mach F et al. Proc Natl Acad Sci USA, 1997, 94: 1931-1936
  • 6Peng X et al. Eur J Immunol, 1996, 26: 1 621-627
  • 7Sukhova GK et al. Circulation, 1999, 99: 2503-2509
  • 8Herman MP et al. Circulation, 2001, 104: 1899-1904
  • 9Schonbeck U et al. Proc Natl Acad Sci USA, 2000, 97: 7458-7463
  • 10Melter M et al. Blood, 2000, 96: 3801-3808

共引文献8

同被引文献8

  • 1金元玖,李正信,苗秀兰,张颖.不同临床类型冠心病患者抗凝血酶III和纤溶系统的变化[J].中国医师杂志,2005,7(3):416-417. 被引量:10
  • 2LOWE G D,SWEETNAM P M,YARNELL J W G, et al. C reactive protein,fibrin D-dimer,and risk of is chemic heart disease[J].Arterioscler Thromb Vasc Biol, 2004,24 : 1957-1962.
  • 3KOHLER H P. Plasminogen activator inhibitor type 1 and coronary artery disease[J]. N Engl J Med, 2000,342 : 1792-1795.
  • 4王振义;李家增;阮长耿.血栓与止血基础理论与临床[M]上海:上海科学技术出版社,2004.
  • 5LOWE G D,SWEETNAM P M,YARNELL J w G. C-reactive protein,fibrin D-dimer,and risk of ischemic heart disease[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2004,(10):1957-1962.
  • 6KOHLER HP. Plasminogen activator inhibitor type 1 and coronary artery disease[J].New England Journal of Medicine,2000,(24):1792-1795.
  • 7De Stefano V,Simioni P. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin[J].Haematologica,2006,(05):695-698.
  • 8马建林,李新明,苏哲坦,李斌,陈关良,王天松,黄白丽,王青,钟文菲,黄雪茹.冠心病并糖尿病患者血栓形成前状态分子标志物变化及机制研究[J].临床心血管病杂志,2003,19(8):468-471. 被引量:4

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部